Health Care sector
Drug makers, biotechnology firms, medical device makers, insurers, and health services providers.
Figures use XLV (Health Care Select Sector SPDR Fund) as an ETF proxy for the sector, compared with SPY (ETF proxy for the S&P 500).
Completed-session closes only. Figures can lag the market and are never intraday. Sector figures use ETF proxies. Source: Yahoo Finance via yahoo-finance2.
Performance against the benchmark
| Period | XLV | SPY | Difference | Holdings rising | Range |
|---|---|---|---|---|---|
| 1D | -1.41% | -1.01% | -0.39 pp | 1 of 10 | Nov 16, 2026 to Nov 17, 2026 |
| 5D | -1.93% | -2.33% | +0.40 pp | 0 of 10 | Nov 10, 2026 to Nov 17, 2026 |
| 1M | +4.83% | -4.04% | +8.86 pp | 5 of 10 | Oct 16, 2026 to Nov 17, 2026 |
| 3M | +11.31% | -4.97% | +16.28 pp | 8 of 10 | Aug 17, 2026 to Nov 17, 2026 |
| YTD | +21.15% | +8.25% | +12.90 pp | 9 of 10 | Dec 31, 2025 to Nov 17, 2026 |
| 1Y | +24.15% | +11.22% | +12.93 pp | 9 of 10 | Nov 17, 2025 to Nov 17, 2026 |
| 5Y | +50.25% | +67.28% | -17.03 pp | 7 of 10 | Nov 17, 2021 to Nov 17, 2026 |
Year to date, indexed to 100
XLV against SPY over the selected period. The sector line is blue and solid; SPY is amber and dashed.
- XLV return
- +21.15%
- SPY return
- +8.25%
- Relative
- +12.90 pp
- Index at the end
- 121.1
Year to date. Indexed to 100 on Dec 31, 2025, through Nov 17, 2026. XLV ends at 121.1, up 21.15 percent; SPY ends at 108.2, up 8.25 percent.
Show chart values as a table
| Date | XLV | SPY |
|---|---|---|
| Dec 31, 2025 | 100.0 (0.0%) | 100.0 (0.0%) |
| Jan 29, 2026 | 99.4 (-0.6%) | 101.8 (+1.8%) |
| Feb 27, 2026 | 103.5 (+3.5%) | 100.6 (+0.6%) |
| Mar 30, 2026 | 93.3 (-6.7%) | 92.9 (-7.1%) |
| Apr 27, 2026 | 93.1 (-6.9%) | 105.2 (+5.2%) |
| May 26, 2026 | 96.3 (-3.7%) | 110.4 (+10.4%) |
| Jun 24, 2026 | 99.9 (-0.1%) | 108.1 (+8.1%) |
| Jul 23, 2026 | 105.2 (+5.2%) | 108.8 (+8.8%) |
| Aug 21, 2026 | 113.8 (+13.8%) | 112.9 (+12.9%) |
| Sep 21, 2026 | 110.5 (+10.5%) | 114.3 (+14.3%) |
| Oct 19, 2026 | 114.9 (+14.9%) | 113.3 (+13.3%) |
| Nov 17, 2026 | 121.1 (+21.1%) | 108.2 (+8.2%) |
Relative performance
XLV return minus the SPY return, in percentage points. The selected period is marked. A missing bar means that period did not pass the quality checks.
Risk and trend measures
- 1-year volatility (annualised)
- 16.9%
- Worst peak-to-trough fall, 1 year
- -10.47%
- Versus 50-day average
- Above
- Transparent sector score
- 76 / 100
Rotation group:Top groupLeading
In the top group of sectors on this measure. Weighted relative momentum versus the benchmark is +15.1 percentage points. 50% of covered holdings rose over the past month. The sector proxy is above its 50-day average.
The score is a descriptive percentile blend of momentum, stability, drawdown, and breadth across the eleven sectors. It is not a rating or a recommendation. See the formula.
Industry breakdown
- Pharmaceuticals
- Biotechnology
- Medical equipment
- Managed care
- Health care services
Industries are the typical groups inside this sector. Industry-level returns need licensed classification data and are not shown.
What tends to drive it
- Drug and device approvals
- Patent expirations
- Reimbursement and drug-pricing policy
- Aging populations
Risks to understand
- Clinical trial and approval outcomes are uncertain
- Pricing and policy changes can hit earnings
- Patent cliffs reduce revenue
Largest holdings of the ETF proxy
Largest disclosed holdings only (10 of 10 requested). Holdings dates are not published by the source. They represent about 61% of the fund.
| Holding | Weight | YTD return | 1M vs sector | 1Y volatility | 50-day trend |
|---|---|---|---|---|---|
| LLYEli Lilly and Co | 16.9% | +32.52% | +7.92 pp | 35.2% | Above |
| JNJJohnson & Johnson | 9.8% | +36.84% | +4.23 pp | 21.1% | Above |
| ABBVAbbVie Inc | 7.8% | +31.99% | -2.23 pp | 25.2% | Above |
| MRKMerck & Co Inc | 5.5% | +39.02% | -6.59 pp | 29.9% | Below |
| UNHUnitedHealth Group Inc | 5.4% | +20.38% | -7.75 pp | 34.7% | Below |
| TMOThermo Fisher Scientific Inc | 3.8% | +18.85% | -5.29 pp | 30.1% | Above |
| AMGNAmgen Inc | 3.7% | +42.77% | +1.06 pp | 28.7% | Above |
| GILDGilead Sciences Inc | 3.1% | +41.21% | +4.18 pp | 27.3% | Above |
| ABTAbbott Laboratories | 2.7% | -14.35% | -5.00 pp | 28.5% | Above |
| PFEPfizer Inc | 2.6% | +21.99% | -7.17 pp | 21.1% | Below |
Breadth and this table cover the largest disclosed holdings only, not every company in the sector. Holdings dates are not published by the source.
Recent headlines
- Sector Update: Healthcare Stocks Retreat Late Afternoon (opens the publisher in a new tab)
MT Newswires · Nov 17, 2026
- Sector Update: Healthcare (opens the publisher in a new tab)
MT Newswires · Nov 17, 2026
- Sector Update: Healthcare Stocks Retreat Tuesday Afternoon (opens the publisher in a new tab)
MT Newswires · Nov 17, 2026
Headlines link to their publishers and are shown as context only. They are not tied to price moves and are not recommendations.
Rotation quadrant
Health Care is marked in blue. The axes stay on the published 3-month and 1-month windows, so this chart does not follow the period selector.
Stored rotation history
| Session | Group | Quadrant | Outcome |
|---|---|---|---|
| Nov 17, 2026 | Top group | Leading | Pending |
| Nov 16, 2026 | Top group | Leading | Pending |
| Nov 13, 2026 | Top group | Leading | Pending |
| Nov 12, 2026 | Top group | Leading | Pending |
| Nov 11, 2026 | Top group | Leading | Pending |
| Nov 10, 2026 | Top group | Leading | hit |
Source: Yahoo Finance via yahoo-finance2 (Reference use only; not a redistribution licence). Session: Nov 17, 2026. Method versions: sector-metrics-v1, sector-score-v1, rotation-v1, gics-11-etf-proxy-v1. Prices are adjusted for distributions. How these figures are built
Sector Intelligence is educational research. It describes what sector ETF proxies did over completed sessions and how a transparent rule groups them. It is not investment advice, a recommendation to buy or sell, or a prediction. Past performance does not indicate future results.
